A limitation in this study is that epacadostat is likely to impact all IDO1-expressing cells within the tumor microenvironment, and a specific role of endothelial IDO1 in affecting T-cell activation can only be formally proven by specifically knocking out IDO1 in endothelial cells. Here, IDO1 is linked to neoplasm.